A rapid, functional assay in frog melanophore cells for the erythropoietin receptor (EPOR), a member of the cytokine receptor family, is demonstrated. A chimeric receptor that comprised the extracellular portion of the murine EPOR and the transmembrane and intracellular domains of the human epidermal growth factor receptor (EGFR) was subcloned into the expression vector pJG3.6. When the full-length EGFR was expressed in melanophores, EGF but not EPO mediated pigment dispersion in a time- and dose-dependent manner with an EC50 of 12.6 ± 2.9 pM. However, when the chimeric EPOR/EGFR was expressed, EPO but not EGF stimulated pigment dispersion in a time- and dose-dependent manner with an EC50 of 380 ± 107 pM. Neither EGF nor EPO had any effect on pigment dispersion in wild-type melanophores. EGF- and EPO-mediated pigment dispersion was blocked by the bisindolylmaleimide protein kinase C inhibitor Ro 31-8220. This study extends the use of the melanophore-based bioassay to include cytokine receptors in addition to G protein- and tyrosine kinase-coupled receptors. It represents a potentially powerful method for screening of combinatorial libraries to identify novel small molecule agonists and antagonists to this clinically important class of binding sites as well as performing studies of functional ligand-receptor interactions.
References
1.
Potenza, M.N., Graminski, G.F., Lerner, M.R. (1992). A method for evaluating the effects of ligands upon G, protein coupled receptors using a recombinant melanophore-based bioassay. Anal. Biochem.206:315-322.
2.
Graminski, G.F., Jayawickreme, C.K., Potenza, M.N., Lerner, M.R. (1993). Pigment dispersion in frog melanophores can be induced by a phorbol ester or stimulation of a recombinant receptor that activates phospholipase C. J. Biol. Chem.268:5957-5964.
3.
Graminski, G.F., Lerner, M.R. (1994). A rapid bioassay for platelet-derived growth factor /3-receptor function. Nature Biotechnol. 12:1008-1011.
4.
Potenza, M.N., Graminski, G.F., Schmauss, C., Lerner, M.R. (1994). Functional expression and characterization of human D2 and D3 dopamine receptors. J. Neurosci.14:1463-1476.
5.
Jayawickreme, C.K., Quillan, J.M., Graminski, G.F., Lerner, M.R. (1994). Discovery and structure function analysis of α-melanocyte stimulating hormone antagonists. J. Biol. Chem.269:29846-29854.
6.
Jayawickreme, C.K., Graminski, G.F., Quillan, J.M., Lerner, M.R. (1994). Creation and functional screening of a multi-use peptide library. Proc. Natl. Acad. Sci. U.S.A.91:1614-1618.
7.
Bazan, J.F. (1993). Emerging families of cytokines and receptors. Curr. Biol.3:603-606.
8.
Heldin, C.H. (1995). Dimerization of cell surface receptors in signal transduction. Cell80:213-223.
9.
IhIe, J.N., Wittuhn, B.A., Quelle, F.W., Yamamoto, K., Silvennoinen. (1995). Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol.13:369-398.
10.
D'Andrea, A.D., Lodish, H.F., Wong, G.G. (1989). Expression cloning of the murine erythropoietin receptor. Cell57:277-285.
11.
Watowich, S.S., Yoshimura, A., Longmore, G.D., Hilton, D.J., Yoshimura, Y., Lodish, H.F. (1992). Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. U.S.A.89:2140-2144.
12.
Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A., Lodish, H.F. (1993). Structure, function, and activation of the erythropoietin receptor. Blood81:2223-2236.
13.
Wrighton, N.C., Farrell, F.X., Chang, R., Kashyap, A.K., Barbone, F.P., Mulcahy, L.S., Johnson, D.L., Barrett, R.W., Jolliffe, L.K., Dower, W.J. (1996). Small peptides as potent mimetics of the protein hormone erythropoietin. Science273:458-464.
14.
Ohashi, H., Maruyama, K., Liu, Y.-C., Yoshimura, A. (1994). Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc. Natl. Acad. Sci. U.S.A.91:158-162.
15.
Riedel, H., Dull, T.J., Honegger, A.M., Schlessinger, J., Ullrich, A. (1989). Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J.8:2943-2954.
16.
Rovelli, G., Heller, R.A., Canossa, M., Shooter, E.M. (1993). Chimeric tumor necrosis factor-TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells. Proc. Natl. Acad. Sci. U.S.A.90:8717-8721.
17.
Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Yarden, Y., Libermann, T.A., Schlessinger, J., Downward, J., Mayes, E.L.V., Whittle, N., Waterfield, M.D., Seeburg, P.H. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 eidermoid carcinoma cells. Nature309:418-425.
18.
Velu, T.J., Vass, W.C., Lowy, D.R., Beguinot, L. (1989). Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation. Mol. Cell. Biol.9:1772-1778.
19.
Wilkinson, S.E., Parker, P.J., Nixon, J.S. (1993). Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J.294:335-337.
20.
Lowman, H.B., Wells, J.A. (1993). Affinity maturation of human growth hormone by monovalent phage display. J. Mol. Biol.234:564-578.
21.
Saggio, I., Gloaguen, I., Poiana, G., Laufer, R. (1995). CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction. EMBO J.14:3045-3054.
22.
Defoort, J.P., Nardelli, B., Huang, W., Ho, D.D., and Tam, J.P. (1992). Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. Natl. Acad. Sci. U.S.A.89:3879-3883.
23.
Wallace, A., Altamura, S., Toniatti, C., Vitelli, A., Bianchi, E., Delmastro, P., Ciliberto, G., Pessi, A. (1994). A multimeric synthetic peptide combinatorial library. Peptide Res.7:27-31.
24.
Seed, B. (1994). Making agonists of antagonists. Chemn. Biol.1:125-129.
25.
Rodseth, L.E., Brandhuber, B., Devine, T.Q., Eck, M.J., Hale, K., Naismith, J.H., Sprang, S.R. (1994). Two crystal forms of the extracellular domain of type I tumor necrosis factor receptor. J. Mol. Biol.239:332-335.
26.
Livnah, O., Stura, E.A., Johnson, D.L., Middleton, S.A., Mulcahy, L.S., Wrighton, N.C., Dower, W.J., Jolliffe, L.K., Wilson, L.A. (1996). Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science273:464-471.
